Correlative study between C-reactive protein, clinical severity, and nerve conduction studies in Guillain-Barrè syndrome

Table 6 Multivariate regression analysis for significant findings in GBS patients with serum CRP > 6 mg/dl

Variable	B	SE	Wald	Sig.	Exp(B)	95.0% CI
Variable	B	SE	Wald	Sig.	Exp(B)	Lower	Upper
Had GE	1.82	0.56	7.12	0.04*	3.45	2.12	7.14
Positive craniobulbar manifestation	0.81	0.43	0.53	0.61	0.79	0.354	1.791
Need for MV	3.12	0.54	11.22	< 0.001**	9.56	4.56	16.34
Disability score > 4	3.83	0.64	5.98	0.03*	2.98	1.85	4.34
Absent motor response	1.67	0.45	7.88	0.02*	2.38	1.98	6.55
Low CMAP amplitude	−0.26	0.39	0.43	0.76	0.85	0.353 0.48	0.353 0.99
Absent sensory response	−1.56	0.54	7.45	0.01*	2.76	1.87	7.86

CRP C-reactive protein, B the estimated logit coefficient, SE standard error, CI confidence interval, GE gastroenteritis, MV mechanical ventilator, CMAP compound motor action potential, Sig. significance
*: significat
**: highly significant